$FHTX SEC Filings

Filed On	Filing
05 Oct 2026	Form 3: Bvf Partners L P/IL, 10% owner and 9 others Holds 4,494,462 shares of Common Stock, $0.0001 par value per share
05 Oct 2026	SCHEDULE 13G/A
01 Oct 2026	8-K: Cost Associated with Exit or Disposal Activities; Regulation FD Disclosure –Foghorn and Lilly will not advance FHD-909; The Collaboration also will not advance the Selective SMARCA2 degrader program
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
25 Jun 2026	Form 4: Duty Stuart, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Biller Scott, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Gallagher Neil, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Mendelsohn Michael, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Smith Ian F, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Gill Simba, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Parshall B Lynne, Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Cole Douglas G., Director Granted 28,000 Stock Options (Right to buy) ($114K)
25 Jun 2026	Form 4: Lynch Thomas J. Jr., Director Granted 28,000 Stock Options (Right to buy) ($114K)
24 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
15 May 2026	SCHEDULE 13G/A
14 May 2026	SCHEDULE 13G/A
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
06 May 2026	SCHEDULE 13G/A

Comments